Novel integrated multiomics analysis reveals a key role for integrin beta-like 1 in wound scarring

Sang Eun Kim(University of Nagasaki), Ryoichi Mori(Nagasaki University), Kento Takaya(Tufts University), Yukari Nakajima(Keio University), Shigeto Seno(The University of Osaka), Kazuo Kishi(Keio University), Masahiro Nakashima(Nagasaki University), Kazuya Ikematsu(Nagasaki University), Takehiko Murase(University of Nagasaki), Ryota Noda(University of Nagasaki), Seiya Mizuno(National Institute of Animal Health), Shoichiro Kameoka(The University of Osaka), Satoru Takahashi(University of Tsukuba), Yu‐Chen Liu(Osaka International Cancer Institute), Paul Martin(University of Bristol), Takahiro Motoyama(Nagasaki University), Daisuke Motooka(The University of Osaka), Katsiaryna Tratsiakova(Nagasaki University), Daisuke Okuzaki(The University of Osaka)
EMBO Reports
November 18, 2024
10.1038/s44319-024-00322-3
Cited by 6

Related Papers

Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
|Hepatology|2013|1k
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
|Gastroenterology|2003|554
Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B
|Gastroenterology|2006|414
CircNet: a database of circular RNAs derived from transcriptome sequencing data
|Nucleic Acids Research|2015|370
Epigenetic reprogramming during wound healing: loss of polycomb‐mediated silencing may enable upregulation of repair genes
|EMBO Reports|2009|167